Day: April 13, 2023

HOUSTON, April 13, 2023 (GLOBE NEWSWIRE) — U.S. Energy Corp. (Nasdaq: USEG, “U.S. Energy” or the “Company”), a growth-focused energy company engaged in the operation of high-quality producing oil and natural gas assets, today reported financial and operating results for the three and twelve months-ended December 31, 2022. FULL YEAR 2022 HIGHLIGHTSRecord production of 1,700 barrels of oil equivalent per day (“Boe/d”); Adjusted EBITDA of $15.0 million; Net cash provided by operating activities of $10.9 million; Free cash flow, excluding expenditures for acquisitions, of $4.7 million; Initiated a quarterly cash dividend, and returned $1.7 million to shareholders; Oil and gas related capital expenditures of $6.2 million; Year-end outstanding debt balance of $12.0 million, $4.4 million of cash, total liquidity of $12.4 million, and...

NEW YORK, April 13, 2023 (GLOBE NEWSWIRE) — FTAI Aviation Ltd. (NASDAQ: FTAI; the “Company” or “FTAI Aviation”) plans to announce its financial results for the first quarter after the closing of Nasdaq on Wednesday, April 26, 2023. A copy of the press release and an earnings supplement will be posted to the Investor Relations section of the Company’s website, https://www.ftaiaviation.com/. In addition, management will host a conference call on Thursday, April 27, 2023 at 8:00 A.M. Eastern Time. The conference call may be accessed by registering via the following link https://register.vevent.com/register/BIcf941a08770d4294aedae237f81c0494. Once registered, participants will receive a dial-in and unique pin to access the call. A simultaneous webcast of the conference call will be available to the public on a listen-only...

DELSON, Quebec, April 13, 2023 (GLOBE NEWSWIRE) — Goodfellow Inc. (TSX: GDL) (the “Company” or “Goodfellow”) announced today its financial results for the first quarter ended February 28, 2023. The Company reported a net loss of $211 thousand or $0.02 per share compared to net earnings of $5.1 million or $0.60 per share a year ago. Consolidated sales for the three months ended February 28, 2023 were $105.9 million compared to $129.4 million last year. Consumer demand in the first quarter of 2023 was significantly lower as compared to uncharacteristically high levels seen in the same period last year. This slowdown is attributed to supply finally outpacing demand, as well as growing unease around rising inflation and interest rates. Results remain comparable to pre-pandemic levels for the same period, which has been historically...

PHOENIX, April 13, 2023 (GLOBE NEWSWIRE) — MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today reported financial results for the three months and full-year ended December 31, 2022. “Since assuming the role of CEO in January 2022, I have been impressed by the many growth opportunities addressable by both our pharmacy services and pharmacy technology solutions,” said Mark Doerr, Chief Executive Officer of MedAvail. “However, I believe it is in the best interest of our company to balance topline growth with an alternative path that targets accelerated profitability. As such, we made the difficult decision earlier this year to restructure and sell a majority of our SpotRx pharmacy services assets to CVS. This action will reduce our operating expense run rate by $35 million to $37 million...

Licensed to Gilead a new development candidate, NX-0479/GS-6791, a targeted protein degrader of IRAK4, resulting in a $20 million payment Expanded therapeutic area potential of protein degradation pipeline with Gilead in rheumatoid arthritis and other inflammatory diseases Achieved an additional $7.5 million in research milestones in collaborations with Gilead and Sanofi Maintained strong financial position with cash and marketable securities of $325.6 million as of February 28, 2023 SAN FRANCISCO, April 13, 2023 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with hematologic malignancies and solid tumors, today reported financial results for the first quarter ended February 28, 2023 and provided a corporate...

HINGHAM, Mass, April 13, 2023 (GLOBE NEWSWIRE) — HINGHAM INSTITUTION FOR SAVINGS (NASDAQ: HIFS), Hingham, Massachusetts announced results for the quarter ended March 31, 2023. Earnings Net income for the quarter ended March 31, 2023 was $8,510,000 or $3.96 per share basic and $3.87 per share diluted, as compared to $11,864,000 or $5.54 per share basic and $5.38 per share diluted for the same period last year. The Bank’s annualized return on average equity for the first quarter of 2023 was 8.67%, and the annualized return on average assets was 0.82%, as compared to 13.10% and 1.37% for the same period last year. Net income per share (diluted) for the first quarter of 2023 decreased by 28% compared to the same period in 2022. Core net income for the quarter ended March 31, 2023, which represents net income excluding the after-tax...